U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Syringocystadenocarcinoma Papilliferum

MedGen UID:
1699131
•Concept ID:
C5231079
•
Neoplastic Process
Synonym: Syringocystadenocarcinoma papilliferum
SNOMED CT: Syringocystadenocarcinoma papilliferum (822966000)

Definition

A sweat gland carcinoma usually arising from a pre-existing syringocystadenoma papilliferum. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVSyringocystadenocarcinoma Papilliferum

Recent clinical studies

Etiology

A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review.
McBride JD, Billings SD, Komforti MK
J Cutan Pathol 2021 Nov;48(11):1387-1391. Epub 2021 Jun 16 doi: 10.1111/cup.14080. PMID: 34089523
Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases.
Zhang Y, Kong YY, Cai X, Shen XX, Kong JC
J Cutan Pathol 2017 Jun;44(6):538-543. Epub 2017 Apr 17 doi: 10.1111/cup.12934. PMID: 28337777
Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
Arslan H, Diyarbakrl M, Batur S, Demirkesen C
J Craniofac Surg 2013 Jan;24(1):e38-40. doi: 10.1097/SCS.0b013e31826cffc6. PMID: 23348331

Diagnosis

Anogenital syringocystadenocarcinoma papilliferum in situ or anaplastic extramammary Paget disease? A unifying concept and review of the literature.
Sheldon JD, Buckley K, Ulman C, Chung CG
J Cutan Pathol 2021 Aug;48(8):1075-1079. Epub 2021 May 13 doi: 10.1111/cup.14029. PMID: 33893742
Syringocystadenocarcinoma papilliferum with coexisting trichoblastoma: A case report with review of literature.
Muthusamy RK, Mehta SS
Indian J Dermatol Venereol Leprol 2017 Sep-Oct;83(5):574-576. doi: 10.4103/ijdvl.IJDVL_755_16. PMID: 28656914
Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
Chen J, Beg M, Chen S
Am J Dermatopathol 2016 Oct;38(10):762-5. doi: 10.1097/DAD.0000000000000687. PMID: 27533073
Syringocystadenocarcinoma papilliferum of the eyelid.
Hoguet AS, Dolphin K, McCormick SA, Milman T
Ophthalmic Plast Reconstr Surg 2012 Jan-Feb;28(1):e27-9. doi: 10.1097/IOP.0b013e318216366a. PMID: 22266788
Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature.
Leeborg N, Thompson M, Rossmiller S, Gross N, White C, Gatter K
Arch Pathol Lab Med 2010 Aug;134(8):1205-9. doi: 10.5858/2009-0399-CR.1. PMID: 20670144

Therapy

Anogenital syringocystadenocarcinoma papilliferum in situ or anaplastic extramammary Paget disease? A unifying concept and review of the literature.
Sheldon JD, Buckley K, Ulman C, Chung CG
J Cutan Pathol 2021 Aug;48(8):1075-1079. Epub 2021 May 13 doi: 10.1111/cup.14029. PMID: 33893742

Prognosis

Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases.
Zhang Y, Kong YY, Cai X, Shen XX, Kong JC
J Cutan Pathol 2017 Jun;44(6):538-543. Epub 2017 Apr 17 doi: 10.1111/cup.12934. PMID: 28337777
Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
Chen J, Beg M, Chen S
Am J Dermatopathol 2016 Oct;38(10):762-5. doi: 10.1097/DAD.0000000000000687. PMID: 27533073
Syringocystadenocarcinoma Papilliferum In Situ-Like Changes in Extramammary Paget Disease: A Report of 11 Cases.
Konstantinova AM, Kacerovska D, Stewart CJ, Szepe P, Pitha J, Sulc M, Bencik V, Michal M, Shideler B, Kerl K, Kazakov DV
Am J Dermatopathol 2016 Dec;38(12):882-886. doi: 10.1097/DAD.0000000000000554. PMID: 26863065
Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
Peterson J, Tefft K, Blackmon J, Rajpara A, Fraga G
Dermatol Online J 2013 Sep 14;19(9):19620. PMID: 24050294
Syringocystadenocarcinoma papilliferum of the eyelid.
Hoguet AS, Dolphin K, McCormick SA, Milman T
Ophthalmic Plast Reconstr Surg 2012 Jan-Feb;28(1):e27-9. doi: 10.1097/IOP.0b013e318216366a. PMID: 22266788

Clinical prediction guides

Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum.
Bun S, Goto K, Oishi T, Kiyohara Y, Tsutsumida A, Yoshikawa S
Am J Dermatopathol 2022 Nov 1;44(11):850-854. Epub 2022 Jul 19 doi: 10.1097/DAD.0000000000002262. PMID: 35925548
Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
Chen J, Beg M, Chen S
Am J Dermatopathol 2016 Oct;38(10):762-5. doi: 10.1097/DAD.0000000000000687. PMID: 27533073
Syringocystadenocarcinoma Papilliferum In Situ-Like Changes in Extramammary Paget Disease: A Report of 11 Cases.
Konstantinova AM, Kacerovska D, Stewart CJ, Szepe P, Pitha J, Sulc M, Bencik V, Michal M, Shideler B, Kerl K, Kazakov DV
Am J Dermatopathol 2016 Dec;38(12):882-886. doi: 10.1097/DAD.0000000000000554. PMID: 26863065

Supplemental Content

Table of contents

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...